Surgery versus SABR for resectable non-small-cell lung cancer

The pooled analysis of two independent phase 3 trials by Joe Chang and colleagues1 has shown the potential to use stereotactic ablative radiotherapy (SABR) for operable stage I non-small-cell lung cancer. [...]the absence of a randomised comparator group means that CtE data can only be compared with...

Full description

Saved in:
Bibliographic Details
Published in:The lancet oncology 2015-08, Vol.16 (8), p.e373-e374
Main Authors: Dearman, Charles, van As, Nicholas, Crellin, Adrian, Slevin, Nicholas, Sharma, Ricky A
Format: Article
Language:English
Subjects:
Anterior Temporal Lobectomy
Carcinoma, Non-Small-Cell Lung - radiotherapy
Carcinoma, Non-Small-Cell Lung - surgery
Female
Funding
Hematology, Oncology and Palliative Medicine
Humans
Lung cancer
Male
Neoplasm Recurrence, Local - radiotherapy
Neoplasm Recurrence, Local - surgery
Radiation therapy
Radiosurgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pooled analysis of two independent phase 3 trials by Joe Chang and colleagues1 has shown the potential to use stereotactic ablative radiotherapy (SABR) for operable stage I non-small-cell lung cancer. [...]the absence of a randomised comparator group means that CtE data can only be compared with published medical literature and historic controls, as an assessment of so-called relative effectiveness.
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(15)00145-X